Proscia: Expanding the industry’s most comprehensive portfolio of AI applications  PHILADELPHIA and PARIS—October 15, 2025—Proscia®, a pathology AI company, will add AI biomarker detection for skin tissue to...

Proscia: Pathology’s transition from glass slides to digital images has opened a huge frontier, enabling the application of artificial intelligence (AI) to improve everything from workflow efficiency to patient outcomes. However, developing...

Artificial intelligence for Dermatopathology: Current Trends and The Road Ahead Abstract Artificial intelligence (AI), including deep learning methods that leverage neural network-based algorithms, hold significant promise for...

U.S. Patent No. 10,460,150 centers around the use of machine learning to classify skin biopsies PHILADELPHIA, October 30, 2019 – Proscia, a leading provider of digital pathology software, has been granted U.S. Patent No. 10,460,150 by...

In many industries, there is standard 80/20 rule, which dictates that 80 percent of your time will be spent on 20 percent of your work. The remaining 80 percent of your work takes only 20 percent of your time. In medicine in general - and in...

Landmark agreement positions Proscia to transform dermatopathology market − and opens doors to additional lab partnerships PHILADELPHIA -- Proscia Inc., creators of AI-powered digital pathology software, today announced it has...